Literature DB >> 29152950

Investigation of class-d beta-lactamases causing carbapenem resistance in clinical Acinetobacter baumannii isolates

Iskandar Davandeh, Bayrı Eraç, Sabire Şöhret Aydemir.   

Abstract

Background/aim: Acinetobacter baumannii is an important causative agent of nosocomial infections, and carbapenems have been frequently used in the treatment of these infections. This study was designed to investigate the prevalence of primary carbapenem hydrolyzing oxacillinase (CHO) types in clinical A. bumannii strains. Materials and methods: Minimum inhibitory concentration (MIC) values of 76 imipenem nonsusceptible A. baumannii strains, isolated from a tertiary care hospital, were determined by microdilution method. The clonal relationship of the isolates was analyzed with enterobacterial repetitive intergenic consensus (ERIC)-PCR, and the presence of CHO major groups (OXA-23; OXA-24, OXA-51, and OXA-58 groups) was investigated with multiplex PCR.
Results: According to the ERIC-PCR patterns, the isolates were distributed in 13 different clones, the largest of which had 40 members. blaOXA-51-group was detected in representatives of all clones, whereas blaOXA-23-group was detected in representatives of all but two small clones. Additionally, the presence of blaOXA-58-group was discovered in the members of two small clones, whereas blaOXA-24-group was not encountered in any of the examined strains.
Conclusion: Molecular fingerprinting revealed that most imipenem-resistant A. baumannii strains were clonally related. blaOXA-23-group and blaOXA-51-group were mostly responsible for the imipenem resistance of the examined A. baumannii strains.

Entities:  

Keywords:  Acinetobacter baumannii; carbapenemase; enterobacterial repetitive intergenic consensus PCR; OXA-genes

Year:  2017        PMID: 29152950     DOI: 10.3906/sag-1607-91

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  5 in total

1.  Investigating Biofilm Formation and Antibiofilm Activity Using Real Time Cell Analysis Method in Carbapenem Resistant Acinetobacter baumannii Strains.

Authors:  Aybala Temel; Bayrı Erac
Journal:  Curr Microbiol       Date:  2022-07-14       Impact factor: 2.343

2.  Dissemination and Genetic Relatedness of Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Isolates from a Burn Hospital in Iraq.

Authors:  Aras A K Shali; Paywast J Jalal; Sehand K Arif
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-05-27       Impact factor: 2.585

3.  Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China.

Authors:  Yongxin Zhao; Kewang Hu; Jisheng Zhang; Yuhang Guo; Xuecai Fan; Yong Wang; Sedzro Divine Mensah; Xiaoli Zhang
Journal:  BMC Infect Dis       Date:  2019-05-22       Impact factor: 3.667

Review 4.  Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii.

Authors:  Corneliu Ovidiu Vrancianu; Irina Gheorghe; Ilda Barbu Czobor; Mariana Carmen Chifiriuc
Journal:  Microorganisms       Date:  2020-06-21

Review 5.  Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens.

Authors:  Corneliu Ovidiu Vrancianu; Irina Gheorghe; Elena-Georgiana Dobre; Ilda Czobor Barbu; Roxana Elena Cristian; Marcela Popa; Sang Hee Lee; Carmen Limban; Ilinca Margareta Vlad; Mariana Carmen Chifiriuc
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.